These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37433658)

  • 1. Management of arrhythmogenic right ventricular cardiomyopathy.
    Al-Aidarous S; Protonotarios A; Elliott PM; Lambiase PD
    Heart; 2024 Jan; 110(3):156-162. PubMed ID: 37433658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Assis FR; Tandri H
    Card Electrophysiol Clin; 2020 Sep; 12(3):329-343. PubMed ID: 32771187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
    J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
    Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrocardiologic opportunities for the treatment of recurrent ventricular tachycardia on the example of a patient with arrhythmogenic right ventricular dysplasia].
    Pudło J; Senderek T; Lelakowska-Pieła M; Bednarek J; Lelakowski J
    Przegl Lek; 2014; 71(6):355-8. PubMed ID: 25344979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
    Marcus GM; Glidden DV; Polonsky B; Zareba W; Smith LM; Cannom DS; Estes NA; Marcus F; Scheinman MM;
    J Am Coll Cardiol; 2009 Aug; 54(7):609-15. PubMed ID: 19660690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.
    Cheng WH; Chung FP; Lin YJ; Lo LW; Chang SL; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang TY; Kuo L; Wu CI; Liu CM; Liu SH; Chen SA
    Rev Cardiovasc Med; 2021 Dec; 22(4):1295-1309. PubMed ID: 34957771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy.
    Rolland T; Badenco N; Maupain C; Duthoit G; Waintraub X; Laredo M; Himbert C; Frank R; Hidden-Lucet F; Gandjbakhch E
    Europace; 2022 Feb; 24(2):278-284. PubMed ID: 34459901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic Right Ventricular Cardiomyopathy.
    Krahn AD; Wilde AAM; Calkins H; La Gerche A; Cadrin-Tourigny J; Roberts JD; Han HC
    JACC Clin Electrophysiol; 2022 Apr; 8(4):533-553. PubMed ID: 35450611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
    Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
    J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
    Ermakov S; Gerstenfeld EP; Svetlichnaya Y; Scheinman MM
    Heart Rhythm; 2017 Apr; 14(4):564-569. PubMed ID: 27939893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Smith W;
    Heart Lung Circ; 2011 Dec; 20(12):757-60. PubMed ID: 21885338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.